alpha-pinene has been researched along with Androgen-Independent Prostatic Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Dhillon, J; Huang, C; Jeong, JH; Lee, YM; Li, F; Liu, Q; Luo, JL; Park, H; Peng, S; Zhong, S | 1 |
1 other study(ies) available for alpha-pinene and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
Tumor-derived OBP2A promotes prostate cancer castration resistance.
Topics: Androgen Antagonists; Androgens; Animals; Antibodies; Bicyclic Monoterpenes; Cell Line, Tumor; CTLA-4 Antigen; Drug Resistance, Neoplasm; Humans; Immune Checkpoint Inhibitors; Lipocalins; Male; Mice; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Tumor Microenvironment | 2023 |